DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) Holdings

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) is an investment fund managing more than 5.02B US dollars. The largest holdings include Nuvalent, GLAUKOS CORP and AERIE PHARMACEUTICALS. In Q3 2022 the fund bought assets of total value of 581.9M US dollars and sold assets of total value of 531.93M US dollars.

$5.02B

portfolio value

+13.44%

quarter

-26.38%

1 year

-8.86%

3 years

-1.73%

5 years

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2016	285639000	264730000
Q2 2016	424698000	273313000
Q3 2016	253581000	431469000
Q4 2016	451563000	171754000
Q1 2017	330580000	343912000
Q2 2017	217733000	683020000
Q3 2017	546070000	282274000
Q4 2017	561473000	233827000
Q1 2018	544642000	404164000
Q2 2018	537675000	364094000
Q3 2018	468815000	602189000
Q4 2018	304417000	459495000
Q1 2019	312160000	207009000
Q2 2019	485286000	506691000
Q3 2019	141944000	363078000
Q4 2019	742446000	193026000
Q1 2020	591791000	627685000
Q2 2020	635914000	730538000
Q3 2020	885140000	486390000
Q4 2020	1422584000	502130000
Q1 2021	1065914000	1042941000
Q2 2021	1419685000	759538000
Q3 2021	780099000	795935000
Q4 2021	390488000	473867000
Q1 2022	231591000	556176000
Q2 2022	506446000	302740000
Q3 2022	581897000	531933000

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology Nuvalent, Inc. Portfolio share: 7.48% Portfolio value: 375.99M Avg. open price: N/A Current price: $34.16 P/L: N/A N/A Q3 2021	share	7.48%	375.99M	N/A	$34.16	N/A	N/A Q3 2021
GLAUKOS CORP Portfolio share: 7.08% Portfolio value: 355.84M Avg. open price: N/A Current price: N/A P/L: N/A Bought +0.69% shares Q2 2022	share	7.08%	355.84M	N/A	N/A	N/A	Bought +0.69% shares Q2 2022
AERIE PHARMACEUTICALS INC Portfolio share: 3.40% Portfolio value: 170.82M Avg. open price: N/A Current price: N/A P/L: N/A Bought +10.79% shares Q3 2022	share	3.40%	170.82M	N/A	N/A	N/A	Bought +10.79% shares Q3 2022
INVITAE CORP Portfolio share: 3.23% Portfolio value: 162.21M Avg. open price: N/A Current price: N/A P/L: N/A Bought +26.62% shares Q1 2022	share	3.23%	162.21M	N/A	N/A	N/A	Bought +26.62% shares Q1 2022
Drug Manufacturers—Specialty & Generic Neurocrine Biosciences, Inc. Portfolio share: 3.20% Portfolio value: 160.66M Avg. open price: $93.32 Current price: $124 P/L: +32.88% Sold -24.84% shares Q3 2022	share	3.20%	160.66M	$93.32	$124	+32.88%	Sold -24.84% shares Q3 2022
Medical Devices AdaptHealth Corp. Portfolio share: 3.07% Portfolio value: 154.43M Avg. open price: $30.7 Current price: $21.92 P/L: -28.60% Sold -26.25% shares Q3 2022	share	3.07%	154.43M	$30.7	$21.92	-28.60%	Sold -26.25% shares Q3 2022
SAREPTA THERAPEUTICS INC Portfolio share: 2.95% Portfolio value: 148.26M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q1 2022	share	2.95%	148.26M	N/A	N/A	N/A	N/A Q1 2022
IONIS PHARMACEUTICALS INC Portfolio share: 2.56% Portfolio value: 128.51M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q2 2022	share	2.56%	128.51M	N/A	N/A	N/A	N/A Q2 2022
TABULA RASA HEALTHCARE INC Portfolio share: 2.30% Portfolio value: 115.53M Avg. open price: N/A Current price: N/A P/L: N/A Bought +34.04% shares Q2 2022	share	2.30%	115.53M	N/A	N/A	N/A	Bought +34.04% shares Q2 2022
Medical Devices Silk Road Medical, Inc Portfolio share: 2.27% Portfolio value: 114.09M Avg. open price: $47.89 Current price: $53.65 P/L: +12.03% Sold -5.29% shares Q3 2022	share	2.27%	114.09M	$47.89	$53.65	+12.03%	Sold -5.29% shares Q3 2022
Health Information Services CareMax, Inc. Portfolio share: 2.24% Portfolio value: 112.45M Avg. open price: N/A Current price: $3.49 P/L: N/A Sold -5.47% shares Q1 2022	share	2.24%	112.45M	N/A	$3.49	N/A	Sold -5.47% shares Q1 2022
APELLIS PHARMACEUTICALS INC Portfolio share: 1.97% Portfolio value: 99.11M Avg. open price: N/A Current price: N/A P/L: N/A Bought +80.00% shares Q1 2022	share	1.97%	99.11M	N/A	N/A	N/A	Bought +80.00% shares Q1 2022
Drug Manufacturers—General Gilead Sciences, Inc. Portfolio share: 1.89% Portfolio value: 94.85M Avg. open price: $59.45 Current price: $87.98 P/L: +47.99% Sold -0.97% shares Q3 2022	share	1.89%	94.85M	$59.45	$87.98	+47.99%	Sold -0.97% shares Q3 2022
NUVASIVE INC Portfolio share: 1.87% Portfolio value: 93.71M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q2 2021	share	1.87%	93.71M	N/A	N/A	N/A	N/A Q2 2021
Drug Manufacturers—Specialty & Generic Viatris Inc. Portfolio share: 1.81% Portfolio value: 90.94M Avg. open price: $14.95 Current price: $10.92 P/L: -26.98% Sold -48.37% shares Q3 2022	share	1.81%	90.94M	$14.95	$10.92	-26.98%	Sold -48.37% shares Q3 2022
Drug Manufacturers—General Biogen Inc. Portfolio share: 1.75% Portfolio value: 88.11M Avg. open price: N/A Current price: $292.75 P/L: N/A N/A Q3 2022	share	1.75%	88.11M	N/A	$292.75	N/A	N/A Q3 2022
ALPHATEC HLDGS INC Portfolio share: 1.62% Portfolio value: 81.43M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2022	share	1.62%	81.43M	N/A	N/A	N/A	N/A Q3 2022
INTERCEPT PHARMACEUTICALS IN Portfolio share: 1.61% Portfolio value: 81.09M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2022	share	1.61%	81.09M	N/A	N/A	N/A	N/A Q3 2022
PACIRA BIOSCIENCES INC Portfolio share: 1.61% Portfolio value: 80.77M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	1.61%	80.77M	N/A	N/A	N/A	N/A Q3 2021
ACCOLADE INC Portfolio share: 1.57% Portfolio value: 79.07M Avg. open price: N/A Current price: N/A P/L: N/A Bought +13.36% shares Q3 2022	share	1.57%	79.07M	N/A	N/A	N/A	Bought +13.36% shares Q3 2022
Biotechnology IVERIC bio, Inc. Portfolio share: 1.52% Portfolio value: 76.13M Avg. open price: $5.84 Current price: $21.89 P/L: +274.85% Sold -18.60% shares Q3 2022	share	1.52%	76.13M	$5.84	$21.89	+274.85%	Sold -18.60% shares Q3 2022
Drug Manufacturers—Specialty & Generic Aerie Pharmaceuticals, Inc. Portfolio share: 1.46% Portfolio value: 73.45M Avg. open price: $27.92 Current price: $15.25 P/L: -45.39% Bought +3.41% shares Q3 2022	share	1.46%	73.45M	$27.92	$15.25	-45.39%	Bought +3.41% shares Q3 2022
INSMED INC Portfolio share: 1.46% Portfolio value: 73.21M Avg. open price: N/A Current price: N/A P/L: N/A Bought +50.00% shares Q1 2022	share	1.46%	73.21M	N/A	N/A	N/A	Bought +50.00% shares Q1 2022
Biotechnology ImmunoGen, Inc. Portfolio share: 1.31% Portfolio value: 65.67M Avg. open price: $4.76 Current price: $5.43 P/L: +14.08% Sold -8.52% shares Q3 2022	share	1.31%	65.67M	$4.76	$5.43	+14.08%	Sold -8.52% shares Q3 2022
GUARDANT HEALTH INC Portfolio share: 1.29% Portfolio value: 65.03M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q2 2022	share	1.29%	65.03M	N/A	N/A	N/A	N/A Q2 2022
Biotechnology Catalyst Pharmaceuticals, Inc. Portfolio share: 1.25% Portfolio value: 62.81M Avg. open price: N/A Current price: $16.98 P/L: N/A N/A Q3 2022	share	1.25%	62.81M	N/A	$16.98	N/A	N/A Q3 2022
Medical Devices Pulmonx Corporation Portfolio share: 1.23% Portfolio value: 61.99M Avg. open price: $40.7 Current price: $6.18 P/L: -84.82% Bought +7.36% shares Q3 2022	share	1.23%	61.99M	$40.7	$6.18	-84.82%	Bought +7.36% shares Q3 2022
Biotechnology Revolution Medicines, Inc. Portfolio share: 1.14% Portfolio value: 57.02M Avg. open price: $21.43 Current price: $24.32 P/L: +13.47% Bought +224.32% shares Q3 2022	share	1.14%	57.02M	$21.43	$24.32	+13.47%	Bought +224.32% shares Q3 2022
INTERCEPT PHARMACEUTICALS IN Portfolio share: 1.12% Portfolio value: 56.09M Avg. open price: N/A Current price: N/A P/L: N/A Bought +60.53% shares Q4 2018	share	1.12%	56.09M	N/A	N/A	N/A	Bought +60.53% shares Q4 2018
Biotechnology Larimar Therapeutics, Inc. Portfolio share: 1.08% Portfolio value: 54.21M Avg. open price: $2.7 Current price: $3.15 P/L: +16.87% Bought +190.58% shares Q3 2022	share	1.08%	54.21M	$2.7	$3.15	+16.87%	Bought +190.58% shares Q3 2022
OAK STR HEALTH INC Portfolio share: 1.04% Portfolio value: 52.49M Avg. open price: N/A Current price: N/A P/L: N/A Bought +277.78% shares Q2 2022	share	1.04%	52.49M	N/A	N/A	N/A	Bought +277.78% shares Q2 2022
NATERA INC Portfolio share: 1.02% Portfolio value: 51.39M Avg. open price: N/A Current price: N/A P/L: N/A Sold -58.47% shares Q3 2022	share	1.02%	51.39M	N/A	N/A	N/A	Sold -58.47% shares Q3 2022
Biotechnology Merus N.V. Portfolio share: 1.01% Portfolio value: 50.50M Avg. open price: $25.46 Current price: $14.2 P/L: -44.23% Bought +26.97% shares Q3 2022	share	1.01%	50.50M	$25.46	$14.2	-44.23%	Bought +26.97% shares Q3 2022
NANOSTRING TECHNOLOGIES INC Portfolio share: 0.97% Portfolio value: 48.66M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2022	share	0.97%	48.66M	N/A	N/A	N/A	N/A Q3 2022
Drug Manufacturers—Specialty & Generic Deciphera Pharmaceuticals, Inc. Portfolio share: 0.92% Portfolio value: 46.09M Avg. open price: $34.4 Current price: $15.02 P/L: -56.34% Sold -60.14% shares Q3 2022	share	0.92%	46.09M	$34.4	$15.02	-56.34%	Sold -60.14% shares Q3 2022
Biotechnology HilleVax, Inc. Portfolio share: 0.90% Portfolio value: 45.34M Avg. open price: $10.93 Current price: $17.5 P/L: +60.11% Bought +1.35% shares Q3 2022	share	0.90%	45.34M	$10.93	$17.5	+60.11%	Bought +1.35% shares Q3 2022
Biotechnology Cogent Biosciences, Inc. Portfolio share: 0.88% Portfolio value: 44.25M Avg. open price: $7.65 Current price: $12.5 P/L: +63.42% Sold -49.52% shares Q3 2022	share	0.88%	44.25M	$7.65	$12.5	+63.42%	Sold -49.52% shares Q3 2022
Drug Manufacturers—Specialty & Generic Evolus, Inc. Portfolio share: 0.86% Portfolio value: 43.39M Avg. open price: $11.38 Current price: $6.98 P/L: -38.67% Bought +48.38% shares Q3 2022	share	0.86%	43.39M	$11.38	$6.98	-38.67%	Bought +48.38% shares Q3 2022
Biotechnology Mirum Pharmaceuticals, Inc. Portfolio share: 0.85% Portfolio value: 42.69M Avg. open price: N/A Current price: $18.33 P/L: N/A Sold -37.36% shares Q3 2022	share	0.85%	42.69M	N/A	$18.33	N/A	Sold -37.36% shares Q3 2022
LIVONGO HEALTH INC Portfolio share: 0.84% Portfolio value: 41.97M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q2 2022	share	0.84%	41.97M	N/A	N/A	N/A	N/A Q2 2022
NEVRO CORP Portfolio share: 0.79% Portfolio value: 39.60M Avg. open price: N/A Current price: N/A P/L: N/A Sold -31.15% shares Q3 2022	share	0.79%	39.60M	N/A	N/A	N/A	Sold -31.15% shares Q3 2022
Biotechnology Cytokinetics, Incorporated Portfolio share: 0.78% Portfolio value: 39.39M Avg. open price: $29.58 Current price: $38.12 P/L: +28.88% Sold -29.92% shares Q3 2022	share	0.78%	39.39M	$29.58	$38.12	+28.88%	Sold -29.92% shares Q3 2022
1LIFE HEALTHCARE INC Portfolio share: 0.78% Portfolio value: 39.37M Avg. open price: N/A Current price: N/A P/L: N/A Sold -16.46% shares Q3 2022	share	0.78%	39.37M	N/A	N/A	N/A	Sold -16.46% shares Q3 2022
Biotechnology Edgewise Therapeutics, Inc. Portfolio share: 0.77% Portfolio value: 38.70M Avg. open price: N/A Current price: $8.83 P/L: N/A N/A Q1 2021	share	0.77%	38.70M	N/A	$8.83	N/A	N/A Q1 2021
PTC THERAPEUTICS INC Portfolio share: 0.75% Portfolio value: 37.55M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q2 2022	share	0.75%	37.55M	N/A	N/A	N/A	N/A Q2 2022
Biotechnology AnaptysBio, Inc. Portfolio share: 0.74% Portfolio value: 37.41M Avg. open price: $31.55 Current price: $28.65 P/L: -9.19% Bought +89.97% shares Q3 2022	share	0.74%	37.41M	$31.55	$28.65	-9.19%	Bought +89.97% shares Q3 2022
Medical Care Facilities Brookdale Senior Living Inc. Portfolio share: 0.74% Portfolio value: 37.11M Avg. open price: $6.67 Current price: $3.34 P/L: -49.90% Bought +1.16% shares Q3 2022	share	0.74%	37.11M	$6.67	$3.34	-49.90%	Bought +1.16% shares Q3 2022
Healthcare Plans Centene Corporation Portfolio share: 0.72% Portfolio value: 36.10M Avg. open price: $58.03 Current price: $86.35 P/L: +48.79% Sold -19.83% shares Q3 2022	share	0.72%	36.10M	$58.03	$86.35	+48.79%	Sold -19.83% shares Q3 2022
Medical Care Facilities Amedisys, Inc. Portfolio share: 0.69% Portfolio value: 34.82M Avg. open price: $105.12 Current price: $90.53 P/L: -13.88% Bought +80.79% shares Q3 2022	share	0.69%	34.82M	$105.12	$90.53	-13.88%	Bought +80.79% shares Q3 2022
Health Information Services Phreesia, Inc. Portfolio share: 0.69% Portfolio value: 34.60M Avg. open price: $25.01 Current price: $28.04 P/L: +12.12% Bought +58.44% shares Q3 2022	share	0.69%	34.60M	$25.01	$28.04	+12.12%	Bought +58.44% shares Q3 2022
Biotechnology BELLUS Health Inc. Portfolio share: 0.65% Portfolio value: 32.53M Avg. open price: $8.47 Current price: $10.02 P/L: +18.28% Bought +24.59% shares Q3 2022	share	0.65%	32.53M	$8.47	$10.02	+18.28%	Bought +24.59% shares Q3 2022
Biotechnology Kura Oncology, Inc. Portfolio share: 0.60% Portfolio value: 30.31M Avg. open price: $17.62 Current price: $15.82 P/L: -10.21% Sold -15.53% shares Q3 2022	share	0.60%	30.31M	$17.62	$15.82	-10.21%	Sold -15.53% shares Q3 2022
Biotechnology Phathom Pharmaceuticals, Inc. Portfolio share: 0.53% Portfolio value: 26.75M Avg. open price: N/A Current price: $11.07 P/L: N/A N/A Q3 2022	share	0.53%	26.75M	N/A	$11.07	N/A	N/A Q3 2022
Biotechnology IDEAYA Biosciences, Inc. Portfolio share: 0.52% Portfolio value: 26.01M Avg. open price: N/A Current price: $17.77 P/L: N/A N/A Q3 2022	share	0.52%	26.01M	N/A	$17.77	N/A	N/A Q3 2022
Biotechnology Verve Therapeutics, Inc. Portfolio share: 0.51% Portfolio value: 25.76M Avg. open price: N/A Current price: $21.42 P/L: N/A N/A Q3 2022	share	0.51%	25.76M	N/A	$21.42	N/A	N/A Q3 2022
HEALTH CATALYST INC Portfolio share: 0.51% Portfolio value: 25.53M Avg. open price: N/A Current price: N/A P/L: N/A Bought +100.00% shares Q3 2022	share	0.51%	25.53M	N/A	N/A	N/A	Bought +100.00% shares Q3 2022
Healthcare Plans Molina Healthcare, Inc. Portfolio share: 0.49% Portfolio value: 24.73M Avg. open price: $120.14 Current price: $335.11 P/L: +178.94% Sold -55.09% shares Q3 2022	share	0.49%	24.73M	$120.14	$335.11	+178.94%	Sold -55.09% shares Q3 2022
NOVAVAX INC Portfolio share: 0.49% Portfolio value: 24.38M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q4 2020	share	0.49%	24.38M	N/A	N/A	N/A	N/A Q4 2020
Biotechnology SpringWorks Therapeutics, Inc. Portfolio share: 0.46% Portfolio value: 23.30M Avg. open price: $33.59 Current price: $24.25 P/L: -27.80% N/A Q3 2022	share	0.46%	23.30M	$33.59	$24.25	-27.80%	N/A Q3 2022
Biotechnology Tarsus Pharmaceuticals, Inc. Portfolio share: 0.45% Portfolio value: 22.67M Avg. open price: N/A Current price: $16.74 P/L: N/A N/A Q2 2022	share	0.45%	22.67M	N/A	$16.74	N/A	N/A Q2 2022
Medical Devices Alphatec Holdings, Inc. Portfolio share: 0.44% Portfolio value: 22.13M Avg. open price: $14.23 Current price: $9.75 P/L: -31.51% Bought +4.64% shares Q3 2022	share	0.44%	22.13M	$14.23	$9.75	-31.51%	Bought +4.64% shares Q3 2022
Biotechnology Insmed Incorporated Portfolio share: 0.41% Portfolio value: 20.68M Avg. open price: $23.5 Current price: $19.89 P/L: -15.36% Bought +215.36% shares Q2 2022	share	0.41%	20.68M	$23.5	$19.89	-15.36%	Bought +215.36% shares Q2 2022
Biotechnology Day One Biopharmaceuticals, Inc. Portfolio share: 0.41% Portfolio value: 20.67M Avg. open price: $16.42 Current price: $21.45 P/L: +30.66% Sold -70.62% shares Q3 2022	share	0.41%	20.67M	$16.42	$21.45	+30.66%	Sold -70.62% shares Q3 2022
Medical Care Facilities Enhabit, Inc. Portfolio share: 0.41% Portfolio value: 20.41M Avg. open price: N/A Current price: $13.68 P/L: N/A N/A Q3 2022	share	0.41%	20.41M	N/A	$13.68	N/A	N/A Q3 2022
Biotechnology Vigil Neuroscience, Inc. Portfolio share: 0.36% Portfolio value: 17.95M Avg. open price: N/A Current price: $12 P/L: N/A N/A Q3 2022	share	0.36%	17.95M	N/A	$12	N/A	N/A Q3 2022
Biotechnology IVERIC bio, Inc. Portfolio share: 0.36% Portfolio value: 17.94M Avg. open price: $5.84 Current price: $21.89 P/L: +274.85% N/A Q3 2022	call	0.36%	17.94M	$5.84	$21.89	+274.85%	N/A Q3 2022
Medical Instruments & Supplies Singular Genomics Systems, Inc. Portfolio share: 0.35% Portfolio value: 17.69M Avg. open price: $3.82 Current price: $1.92 P/L: -49.74% Bought +11.71% shares Q3 2022	share	0.35%	17.69M	$3.82	$1.92	-49.74%	Bought +11.71% shares Q3 2022
XERIS BIOPHARMA HOLDINGS INC Portfolio share: 0.35% Portfolio value: 17.38M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q2 2020	share	0.35%	17.38M	N/A	N/A	N/A	N/A Q2 2020
Biotechnology TG Therapeutics, Inc. Portfolio share: 0.32% Portfolio value: 15.85M Avg. open price: N/A Current price: $8.16 P/L: N/A N/A Q2 2022	share	0.32%	15.85M	N/A	$8.16	N/A	N/A Q2 2022
Shell Companies DA32 Life Science Tech Acquisition Corp. Portfolio share: 0.31% Portfolio value: 15.56M Avg. open price: N/A Current price: $9.89 P/L: N/A N/A Q3 2021	share	0.31%	15.56M	N/A	$9.89	N/A	N/A Q3 2021
Medical Care Facilities The Oncology Institute, Inc. Portfolio share: 0.31% Portfolio value: 15.55M Avg. open price: $7.13 Current price: $1.33 P/L: -81.35% Sold -0.68% shares Q3 2022	share	0.31%	15.55M	$7.13	$1.33	-81.35%	Sold -0.68% shares Q3 2022
Drug Manufacturers—Specialty & Generic Pacira BioSciences, Inc. Portfolio share: 0.31% Portfolio value: 15.53M Avg. open price: $53.65 Current price: $46.75 P/L: -12.86% N/A Q2 2022	share	0.31%	15.53M	$53.65	$46.75	-12.86%	N/A Q2 2022
Health Information Services Sema4 Holdings Corp. Portfolio share: 0.30% Portfolio value: 14.89M Avg. open price: $3.17 Current price: $0.38 P/L: -87.92% Sold -9.95% shares Q3 2022	share	0.30%	14.89M	$3.17	$0.38	-87.92%	Sold -9.95% shares Q3 2022
Biotechnology Rocket Pharmaceuticals, Inc. Portfolio share: 0.28% Portfolio value: 13.88M Avg. open price: $15.46 Current price: $19.03 P/L: +23.08% N/A Q3 2022	share	0.28%	13.88M	$15.46	$19.03	+23.08%	N/A Q3 2022
Biotechnology AN2 Therapeutics, Inc. Portfolio share: 0.25% Portfolio value: 12.45M Avg. open price: $15.07 Current price: $9.14 P/L: -39.35% Bought +22.67% shares Q2 2022	share	0.25%	12.45M	$15.07	$9.14	-39.35%	Bought +22.67% shares Q2 2022
Biotechnology Krystal Biotech, Inc. Portfolio share: 0.24% Portfolio value: 12.19M Avg. open price: N/A Current price: $75.78 P/L: N/A N/A Q3 2022	share	0.24%	12.19M	N/A	$75.78	N/A	N/A Q3 2022
Medical Devices Pacific Biosciences of California, Inc. Portfolio share: 0.23% Portfolio value: 11.73M Avg. open price: N/A Current price: $10.03 P/L: N/A N/A Q3 2022	share	0.23%	11.73M	N/A	$10.03	N/A	N/A Q3 2022
Biotechnology ADC Therapeutics SA Portfolio share: 0.23% Portfolio value: 11.52M Avg. open price: N/A Current price: $3.52 P/L: N/A N/A Q3 2022	share	0.23%	11.52M	N/A	$3.52	N/A	N/A Q3 2022
Biotechnology Vericel Corporation Portfolio share: 0.22% Portfolio value: 11.25M Avg. open price: $15.69 Current price: $22.7 P/L: +44.64% N/A Q3 2022	share	0.22%	11.25M	$15.69	$22.7	+44.64%	N/A Q3 2022
Biotechnology Terns Pharmaceuticals, Inc. Portfolio share: 0.22% Portfolio value: 10.95M Avg. open price: N/A Current price: $6.09 P/L: N/A N/A Q3 2022	share	0.22%	10.95M	N/A	$6.09	N/A	N/A Q3 2022
Shell Companies Eucrates Biomedical Acquisition Corp. Portfolio share: 0.20% Portfolio value: 10.02M Avg. open price: N/A Current price: $9.92 P/L: N/A N/A Q4 2021	share	0.20%	10.02M	N/A	$9.92	N/A	N/A Q4 2021
Shell Companies Sarissa Capital Acquisition Corp. Portfolio share: 0.20% Portfolio value: 10M Avg. open price: N/A Current price: $10.05 P/L: N/A N/A Q4 2021	share	0.20%	10M	N/A	$10.05	N/A	N/A Q4 2021
Biotechnology Alector, Inc. Portfolio share: 0.20% Portfolio value: 9.98M Avg. open price: $19 Current price: $8.68 P/L: -54.32% Sold -27.82% shares Q4 2020	share	0.20%	9.98M	$19	$8.68	-54.32%	Sold -27.82% shares Q4 2020
Shell Companies Senior Connect Acquisition Corp. I Portfolio share: 0.20% Portfolio value: 9.94M Avg. open price: N/A Current price: $10.06 P/L: N/A N/A Q3 2021	share	0.20%	9.94M	N/A	$10.06	N/A	N/A Q3 2021
Shell Companies MedTech Acquisition Corporation Portfolio share: 0.20% Portfolio value: 9.93M Avg. open price: N/A Current price: $10.13 P/L: N/A N/A Q3 2021	share	0.20%	9.93M	N/A	$10.13	N/A	N/A Q3 2021
Shell Companies Revolution Healthcare Acquisition Corp. Portfolio share: 0.20% Portfolio value: 9.82M Avg. open price: N/A Current price: $10.05 P/L: N/A N/A Q3 2021	share	0.20%	9.82M	N/A	$10.05	N/A	N/A Q3 2021
Medical Devices Apollo Endosurgery, Inc. Portfolio share: 0.19% Portfolio value: 9.64M Avg. open price: N/A Current price: $9.99 P/L: N/A N/A Q4 2021	share	0.19%	9.64M	N/A	$9.99	N/A	N/A Q4 2021
Biotechnology Pharvaris N.V. Portfolio share: 0.17% Portfolio value: 8.47M Avg. open price: $18.63 Current price: $2.02 P/L: -89.16% Sold -7.21% shares Q3 2022	share	0.17%	8.47M	$18.63	$2.02	-89.16%	Sold -7.21% shares Q3 2022
Biotechnology POINT Biopharma Global Inc. Portfolio share: 0.15% Portfolio value: 7.73M Avg. open price: N/A Current price: $6.72 P/L: N/A N/A Q3 2022	share	0.15%	7.73M	N/A	$6.72	N/A	N/A Q3 2022
Shell Companies Turmeric Acquisition Corp. Portfolio share: 0.15% Portfolio value: 7.5M Avg. open price: N/A Current price: $10.03 P/L: N/A N/A Q4 2021	share	0.15%	7.5M	N/A	$10.03	N/A	N/A Q4 2021
Shell Companies Ignyte Acquisition Corp. Portfolio share: 0.14% Portfolio value: 7.23M Avg. open price: N/A Current price: $13.05 P/L: N/A N/A Q3 2021	share	0.14%	7.23M	N/A	$13.05	N/A	N/A Q3 2021
Biotechnology PepGen Inc. Portfolio share: 0.13% Portfolio value: 6.76M Avg. open price: N/A Current price: $14.98 P/L: N/A Sold -21.85% shares Q3 2022	share	0.13%	6.76M	N/A	$14.98	N/A	Sold -21.85% shares Q3 2022
Biotechnology Foghorn Therapeutics Inc. Portfolio share: 0.13% Portfolio value: 6.67M Avg. open price: $15.23 Current price: $6.73 P/L: -55.81% Bought +225.51% shares Q2 2022	share	0.13%	6.67M	$15.23	$6.73	-55.81%	Bought +225.51% shares Q2 2022
Biotechnology Inozyme Pharma, Inc. Portfolio share: 0.11% Portfolio value: 5.60M Avg. open price: $16.37 Current price: $1.36 P/L: -91.69% Sold -22.47% shares Q3 2022	share	0.11%	5.60M	$16.37	$1.36	-91.69%	Sold -22.47% shares Q3 2022
NEOGENOMICS INC Portfolio share: 0.11% Portfolio value: 5.57M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q2 2022	share	0.11%	5.57M	N/A	N/A	N/A	N/A Q2 2022
Biotechnology Graybug Vision, Inc. Portfolio share: 0.10% Portfolio value: 4.96M Avg. open price: N/A Current price: $0.63 P/L: N/A N/A Q3 2020	share	0.10%	4.96M	N/A	$0.63	N/A	N/A Q3 2020
Shell Companies Orion Acquisition Corp. Portfolio share: 0.10% Portfolio value: 4.92M Avg. open price: N/A Current price: $10.08 P/L: N/A N/A Q3 2021	share	0.10%	4.92M	N/A	$10.08	N/A	N/A Q3 2021
Biotechnology Werewolf Therapeutics, Inc. Portfolio share: 0.09% Portfolio value: 4.32M Avg. open price: N/A Current price: $1.75 P/L: N/A Sold -45.34% shares Q4 2021	share	0.09%	4.32M	N/A	$1.75	N/A	Sold -45.34% shares Q4 2021
Biotechnology Quantum-Si incorporated Portfolio share: 0.08% Portfolio value: 3.85M Avg. open price: N/A Current price: $2.36 P/L: N/A N/A Q2 2021	share	0.08%	3.85M	N/A	$2.36	N/A	N/A Q2 2021
Biotechnology Annexon, Inc. Portfolio share: 0.07% Portfolio value: 3.60M Avg. open price: N/A Current price: $5.74 P/L: N/A Sold -50.00% shares Q1 2021	share	0.07%	3.60M	N/A	$5.74	N/A	Sold -50.00% shares Q1 2021
Biotechnology Orchard Therapeutics plc Portfolio share: 0.07% Portfolio value: 3.47M Avg. open price: $17.88 Current price: $0.45 P/L: -97.48% Sold -4.28% shares Q3 2020	share	0.07%	3.47M	$17.88	$0.45	-97.48%	Sold -4.28% shares Q3 2020
Biotechnology Kinnate Biopharma Inc. Portfolio share: 0.06% Portfolio value: 2.98M Avg. open price: $31.06 Current price: $7.05 P/L: -77.30% Sold -74.63% shares Q2 2022	share	0.06%	2.98M	$31.06	$7.05	-77.30%	Sold -74.63% shares Q2 2022
Medical Devices Profound Medical Corp. Portfolio share: 0.06% Portfolio value: 2.95M Avg. open price: $18.14 Current price: $5.31 P/L: -70.73% Sold -57.26% shares Q3 2022	share	0.06%	2.95M	$18.14	$5.31	-70.73%	Sold -57.26% shares Q3 2022
NYXOAH S A Portfolio share: 0.06% Portfolio value: 2.86M Avg. open price: N/A Current price: N/A P/L: N/A Bought +51.35% shares Q4 2021	share	0.06%	2.86M	N/A	N/A	N/A	Bought +51.35% shares Q4 2021
Biotechnology Oncorus, Inc. Portfolio share: 0.05% Portfolio value: 2.67M Avg. open price: $32.33 Current price: $0.44 P/L: -98.64% Bought +10.53% shares Q1 2021	share	0.05%	2.67M	$32.33	$0.44	-98.64%	Bought +10.53% shares Q1 2021
Medical Devices Acutus Medical, Inc. Portfolio share: 0.05% Portfolio value: 2.33M Avg. open price: $1.12 Current price: $0.83 P/L: -25.62% Bought +0.12% shares Q3 2022	share	0.05%	2.33M	$1.12	$0.83	-25.62%	Bought +0.12% shares Q3 2022
Medical Devices Delcath Systems, Inc. Portfolio share: 0.03% Portfolio value: 1.55M Avg. open price: N/A Current price: $2.83 P/L: N/A Sold -2.79% shares Q3 2022	share	0.03%	1.55M	N/A	$2.83	N/A	Sold -2.79% shares Q3 2022
CAREMAX INC Portfolio share: 0.03% Portfolio value: 1.26M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q2 2021	share	0.03%	1.26M	N/A	N/A	N/A	N/A Q2 2021
THE ONCOLOGY INSTITUTE INC Portfolio share: 0.01% Portfolio value: 691K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q4 2021	share	0.01%	691K	N/A	N/A	N/A	N/A Q4 2021
Pharmaceutical Retailers MedAvail Holdings, Inc. Portfolio share: 0.01% Portfolio value: 649K Avg. open price: N/A Current price: $0.4 P/L: N/A Sold -26.78% shares Q2 2022	share	0.01%	649K	N/A	$0.4	N/A	Sold -26.78% shares Q2 2022
BUTTERFLY NETWORK INC Portfolio share: 0.01% Portfolio value: 616K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q1 2021	share	0.01%	616K	N/A	N/A	N/A	N/A Q1 2021
Biotechnology Nuvation Bio Inc. Portfolio share: 0.01% Portfolio value: 550K Avg. open price: $10.45 Current price: $1.94 P/L: -81.44% N/A Q3 2022	share	0.01%	550K	$10.45	$1.94	-81.44%	N/A Q3 2022
Biotechnology Roivant Sciences Ltd. Portfolio share: 0.01% Portfolio value: 390K Avg. open price: N/A Current price: $1.28 P/L: N/A N/A Q4 2021	share	0.01%	390K	N/A	$1.28	N/A	N/A Q4 2021
Biotechnology Cabaletta Bio, Inc. Portfolio share: 0.01% Portfolio value: 302K Avg. open price: N/A Current price: $4.97 P/L: N/A Sold -63.85% shares Q2 2020	share	0.01%	302K	N/A	$4.97	N/A	Sold -63.85% shares Q2 2020
QUANTUM SI INC Portfolio share: 0.00% Portfolio value: 177K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q2 2021	share	0.00%	177K	N/A	N/A	N/A	N/A Q2 2021
SOMALOGIC INC Portfolio share: 0.00% Portfolio value: 53K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.00%	53K	N/A	N/A	N/A	N/A Q3 2021
Ignyte Acquisition Corp. Portfolio share: 0.00% Portfolio value: 45K Avg. open price: N/A Current price: $0.17 P/L: N/A N/A Q3 2021	share	0.00%	45K	N/A	$0.17	N/A	N/A Q3 2021
NUVATION BIO INC Portfolio share: 0.00% Portfolio value: 33K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q1 2021	share	0.00%	33K	N/A	N/A	N/A	N/A Q1 2021
Biotechnology Surrozen, Inc. Portfolio share: 0.00% Portfolio value: 31K Avg. open price: N/A Current price: $0.05 P/L: N/A N/A Q3 2021	share	0.00%	31K	N/A	$0.05	N/A	N/A Q3 2021
MEDTECH ACQUISITION CORP Portfolio share: 0.00% Portfolio value: 20K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.00%	20K	N/A	N/A	N/A	N/A Q3 2021
EUCRATES BIOMEDICAL ACQU COR Portfolio share: 0.00% Portfolio value: 13K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q4 2021	share	0.00%	13K	N/A	N/A	N/A	N/A Q4 2021
Revolution Healthcare Acquisition Corp. Portfolio share: 0.00% Portfolio value: 9K Avg. open price: N/A Current price: $0 P/L: N/A N/A Q3 2021	share	0.00%	9K	N/A	$0	N/A	N/A Q3 2021
Senior Connect Acquisition Corp. I Portfolio share: 0.00% Portfolio value: 10K Avg. open price: N/A Current price: $0.03 P/L: N/A N/A Q3 2021	share	0.00%	10K	N/A	$0.03	N/A	N/A Q3 2021
Orion Acquisition Corp. Portfolio share: 0.00% Portfolio value: 7K Avg. open price: N/A Current price: $0 P/L: N/A N/A Q3 2021	share	0.00%	7K	N/A	$0	N/A	N/A Q3 2021
Biotechnology Windtree Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 6K Avg. open price: N/A Current price: $0.18 P/L: N/A N/A Q2 2020	share	0.00%	6K	N/A	$0.18	N/A	N/A Q2 2020
SARISSA CAPITAL ACQUISITN CO Portfolio share: 0.00% Portfolio value: 7K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q1 2022	share	0.00%	7K	N/A	N/A	N/A	N/A Q1 2022
TURMERIC ACQUISITION CORP Portfolio share: 0.00% Portfolio value: 7K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q4 2021	share	0.00%	7K	N/A	N/A	N/A	N/A Q4 2021
Biotechnology Rhythm Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $22.12 Current price: $27.14 P/L: +22.71% Sold -100.00% shares Q3 2022	share	0.00%	0	$22.12	$27.14	+22.71%	Sold -100.00% shares Q3 2022
ENVISTA HOLDINGS CORPORATION Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: N/A P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	N/A	N/A	Sold -100.00% shares Q3 2022
BENEFITFOCUS INC Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: N/A P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	N/A	N/A	Sold -100.00% shares Q3 2022
Medical Devices Glaukos Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $43.78 Current price: $45.88 P/L: +4.80% Sold -100.00% shares Q3 2022	share	0.00%	0	$43.78	$45.88	+4.80%	Sold -100.00% shares Q3 2022
Biotechnology Xilio Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $2.43 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$2.43	N/A	Sold -100.00% shares Q3 2022
Biotechnology Nkarta, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $8.15 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$8.15	N/A	Sold -100.00% shares Q3 2022
NUVASIVE INC Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: N/A P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	N/A	N/A	Sold -100.00% shares Q3 2022
INSULET CORP Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: N/A P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	N/A	N/A	Sold -100.00% shares Q3 2022
Drug Manufacturers—General Horizon Therapeutics Public Limited Company Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $20.99 Current price: $98.48 P/L: +369.07% Sold -100.00% shares Q3 2022	share	0.00%	0	$20.99	$98.48	+369.07%	Sold -100.00% shares Q3 2022
Biotechnology Syndax Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $25.44 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$25.44	N/A	Sold -100.00% shares Q3 2022
Drug Manufacturers—General Biogen Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $292.75 P/L: N/A Sold -100.00% shares Q3 2022	call	0.00%	0	N/A	$292.75	N/A	Sold -100.00% shares Q3 2022
Medical Devices Outset Medical, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $50 Current price: $21.42 P/L: -57.16% Sold -100.00% shares Q3 2022	share	0.00%	0	$50	$21.42	-57.16%	Sold -100.00% shares Q3 2022
PTC THERAPEUTICS INC Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: N/A P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	N/A	N/A	Sold -100.00% shares Q3 2022
Drug Manufacturers—Specialty & Generic Organogenesis Holdings Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $17.42 Current price: $2.63 P/L: -84.91% Sold -100.00% shares Q3 2022	share	0.00%	0	$17.42	$2.63	-84.91%	Sold -100.00% shares Q3 2022
Biotechnology 89bio, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $8.34 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$8.34	N/A	Sold -100.00% shares Q3 2022
DYNAVAX TECHNOLOGIES CORP Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: N/A P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	N/A	N/A	Sold -100.00% shares Q3 2022
Biotechnology Kezar Life Sciences, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $7.07 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$7.07	N/A	Sold -100.00% shares Q3 2022

Showing TOP 144 DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)?

The biggest position of the DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) is Nuvalent, Inc. (NUVL) with 7.48% portfolio share worth of 375.99M US dollars.

Top 5 DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s holdings represent 24.4% of the portfolio:

Nuvalent, Inc. (NUVL) – 7.48%
GLAUKOS CORP () – 7.08%
AERIE PHARMACEUTICALS INC () – 3.4%
INVITAE CORP () – 3.23%
Neurocrine Biosciences, Inc. (NBIX) – 3.2%

Who is the portfolio manager of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)?

The portfolio manager of the DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) is .

What is the total asset value of the DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) portfolio?

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) total asset value (portfolio value) is 5.02B US dollars.

Who is ?

is the portfolio manager of the DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C).

What is (DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)) fund performance?

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s quarterly performance is +13.44%, annualy -26.38%. In the past 3 years, the value of 's portfolio has decreased by -9%. In the past 5 years, the value of the portfolio has decreased by -2%.

What is the DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) CIK?

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s Central Index Key is 0001009258 .

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) Holdings

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) portfolio value:

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) quarter portfolio value change:

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1 year portfolio value change:

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3 years portfolio value change:

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5 years portfolio value change: